1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.
(
- Contribution to journal › Article
-
Mark
Detecting dic(9;20)(p13.2;p11.2)-positive B-cell precursor acute lymphoblastic leukemia in a clinical setting using fluorescence in situ hybridization
(
- Contribution to journal › Letter
- 2013
-
Mark
Loss of chromosomes is the primary event in near-haploid and low hypodiploid acute lymphoblastic leukemia.
(
- Contribution to journal › Article
- 2011
-
Mark
The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial
(
- Contribution to journal › Article
- 2010
-
Mark
Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.
(
- Contribution to journal › Article
- 2005
-
Mark
Acute leukaemia in children with Down syndrome: a population-based Nordic study
(
- Contribution to journal › Article
- 2003
-
Mark
High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL).
(
- Contribution to journal › Article
-
Mark
Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents
(
- Contribution to journal › Article
- 2002
-
Mark
Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi-institutional collaborative study
(
- Contribution to journal › Article
- 2001
-
Mark
Doxorubicin pharmacokinetics in children with acute lymphoblastic leukemia
(
- Contribution to journal › Published meeting abstract